Moneyview IPO Day 3: GMP ₹0

Welcome back to our daily Moneyview IPO update! As we wrap up Day 3 of the subscription period, it’s time to take a closer look at how investors are responding to this mainboard IPO on the NSE. The issue opened on 2026-09-24 and will close on 2026-09-28, giving potential investors ample time to consider their options. Today, we’re seeing a subscription status that, while not yet explosive, is typical for this stage of an IPO. Let’s dive into the details.

Subscription Status

As of the end of Day 3, the Moneyview IPO is showing zero subscriptions across all categories: Retail, NII (Non-Institutional Investors), and QIB (Qualified Institutional Buyers). The total subscription also stands at 0x. Now, before you panic, this isn’t necessarily a red flag just yet. It’s important to remember that IPO subscriptions often pick up pace significantly in the final two days. Many investors, especially larger institutions like QIBs and NIIs, prefer to wait until the eleventh hour to gauge overall market sentiment and the final demand before committing their capital. The retail segment, while sometimes showing earlier interest, can also see a surge towards the end. This current zero subscription might simply indicate a cautious approach from all investor types, which is not uncommon.

What these numbers *do* tell us is that the market is waiting. There’s no overwhelming demand yet, nor is there any significant selling pressure visible through undersubscription. It’s a neutral ground at this moment. The lot size for Moneyview IPO is 441 shares, and the issue price is fixed at ₹34. This means each application would involve a minimum investment of 441 shares * ₹34, a figure that’s relatively accessible for retail investors.

GMP Update

Moving on to the Grey Market Premium (GMP), the situation remains unchanged. The current GMP for Moneyview IPO is ₹0. Yesterday, it was also at ₹0. This means that, as of today, the grey market is not indicating any premium over the issue price of ₹34. The expected listing price is therefore also at ₹34. A GMP of ₹0 isn’t ideal, as investors often look for a positive GMP to signal potential listing gains. However, it’s crucial to understand that GMP is a speculative indicator and isn’t always accurate. It can fluctuate based on market sentiment and demand observed in the primary market. The fact that it has remained stagnant at ₹0 suggests that the grey market participants aren’t currently placing any extra value on the stock over its IPO price. This could concern investors hoping for an immediate listing pop.

Should You Apply?

So, the big question: should you be applying for the Moneyview IPO? Based on the current data, it’s a mixed bag. The subscription numbers are flat, which means there’s no immediate rush of demand to get excited about. On the flip side, there’s also no sign of a lack of interest, which is also a positive. The GMP at ₹0 is a point of caution. It suggests that the market isn’t anticipating a significant jump on listing day. However, remember that this is still early in the subscription period. Many IPOs that have seen lukewarm interest in the initial days have gone on to be fully subscribed, and sometimes even oversubscribed, by the closing date. The true picture will only emerge in the next two days.

As per SEBI guidelines, it’s always advisable to conduct your own thorough research. Consider the company’s fundamentals, its future prospects, and the overall market conditions. Don’t solely rely on GMP or early subscription data. If the company’s business model and growth potential align with your investment strategy, and you’re comfortable with the risk associated with IPOs, you might still consider applying, especially if you believe in the long-term value. That said, if you’re primarily looking for quick listing gains, the current GMP might make you hesitant. The final decision rests with your investment goals and risk appetite.

View Full Moneyview IPO Details